Daily Stock Market News(Nov 24'2025): Rupee @ 89.49 LOW | RIL Halts Russian Oil | Indigo In Sensex
Автор: Yadnya Investment Academy
Загружено: 2025-11-23
Просмотров: 15240
#RupeeAllTimeLow #SensexRejig #stockmarketindia #ril #tatapower #labourcodes #indianeconomy #FIIOutflow #g20summit #marketupdate
https://shorturl.at/gM97l
How to Use Artificial Intelligence for Investing - Combo of 5 ebooks
Catch the latest market volatility! The Indian Rupee hit a historic low of 89.49 against the USD, driven by massive FII outflows and a record trade deficit. Get the detailed analysis on why the RBI conceded the 88.80 support line.
We cover major corporate and index shakeups: Reliance (RIL) halts Russian crude imports for its export unit due to US sanctions, while Indigo (InterGlobe Aviation) replaces Tata Motors in the Sensex Rejig. Plus, Tata Power signs a massive ₹1,572 Cr deal for a Bhutan hydro project.
Learn how the New Labour Codes are set to formalize 150-200 million workers, promising 3x-4x growth for the organized Staffing sector. Global news includes falling oil prices and the launch of the ACITI Tech Partnership between India, Canada, and Australia at the G20 Summit.
Stay updated with key stock developments on Tata Chemicals, Aurobindo Pharma, and the Adani Group exit from AWL.
00:00 Start
00:16 Oil/Energy Stocks Fall on Trump Ukraine Peace Plan
02:26 Treasury Yields Slide on Potential December Fed Cut
04:08 India, Canada, Australia Launch ACITI Tech Partnership
05:28 Rupee Hits Record Low Amid Outflows and Trade Deficit
07:53 India Business Growth Slows to 6-Month Low
09:10 New Labour Codes Set to Transform Staffing Sector
10:55 FinMin Revives Merger of PSU Insurers
11:47 SEBI to Include REITs in Market Indices
13:04 Kotak Mahindra Leads IDBI Bank Stake Bids
13:48 Tata Chemicals Approves ₹910 Cr Capacity Expansion
14:24 Sensex Indices Undergo Major Rejig
15:20 Tata Power Invests in Bhutan Hydropower Project
16:03 Adani Group Exits Adani Wilmar Stake
16:36 US Court Upholds $194.2M Fine Against TCS
17:33 Aurobindo Pharma Targets Break-Even at China Plant
18:16 Knowledge Section
Complete Fundamental Stock Analysis Tool - Stock-o-meter:
https://investyadnya.in/stock-o-meter
Research Based Ready-made Model Portfolios:
https://investyadnya.in/model-portfolios
Comprehensive Mutual Fund Reviews:
https://investyadnya.in/fund-o-meter
Yadnya Books and eBooks now available:
On Amazon - https://amzn.to/47x0RS4
On Flipkart - https://fktr.in/y3OZ3GF
On our website - https://shop.investyadnya.in
Find us on Social Media and stay connected:
Whatsapp Channel - https://whatsapp.com/channel/0029Va6N...
Blog - https://blog.investyadnya.in
Telegram - http://t.me/InvestYadnya
Facebook Page - / investyadnya
Twitter - / investyadnya
LEGAL DISCLAIMER:
Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services.
DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014:
Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349.
Disclosure with regard to ownership and material conflicts of interest
1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company;
2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance;
3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance.
Disclosure with regard to receipt of Compensation
1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months.
2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: